Three-dimensional bioprinting strategies for oxygen gradient control and precision cancer therapy
Tumor hypoxia is spatially and temporally heterogeneous and contributes to metabolic adaptation, invasion, and treatment resistance. Although three-dimensional cultures can develop oxygen gradients spontaneously, their magnitude and stability are often poorly controlled. Three-dimensional bioprinting can prescribe cell density, diffusion distance, matrix composition, vascular geometry, and oxygen-modulating components. This review compares geometry-driven, material-mediated, and perfusion-based oxygen control, distinguishing direct evidence from bioprinted tumor constructs from hybrid fabrication studies and non-bioprinted transport or biological benchmarks. A semi-quantitative design map links engineering parameters to oxygen outcomes, recommended measurements, and confounders. We examine how these oxygen environments relate to hypoxia-inducible factor signaling, metabolism, stromal interactions, and responses to chemotherapy and radiotherapy. Measurement methods are compared according to the quantity measured, spatial and temporal sampling, calibration, and biological specificity. Patient-derived model establishment and reported ex vivo–clinical response concordance support further translation. The next step is to test whether explicit oxygen engineering improves treatment prediction in matched model comparisons. We propose an iterative workflow connecting target oxygen specifications, fabrication, spatial and longitudinal validation, and treatment testing.
Abedi, K., Sissoko, C., Pun, S., Kappagantula, S., Zucca, B., & Barrile, R. (2026). Modeling glioblastoma niche-by-niche: Recent advancements in bioengineering of organotypic models of glioblastoma for precision medicine. Biofabrication, 18(3), 032004. https://doi.org/10.1088/1758-5090/ae7832
Aguilera-Marquez, J. D. R., Manzanares-Guzmán, A., García-Uriostegui, L., Canales-Aguirre, A. A., Camacho-Villegas, T. A., & Lugo-Fabres, P. H. (2025). Alginate–gelatin hydrogel scaffold model for hypoxia induction in glioblastoma embedded spheroids. Gels, 11(4), 263. https://doi.org/10.3390/gels11040263
Anderson, N. M., & Simon, M. C. (2020). The tumor microenvironment. Current Biology, 30(16), R921-R925. https://doi.org/10.1016/j.cub.2020.06.081
Ayuso, J. M., Monge, R., Martínez-González, A., Virumbrales-Muñoz, M., Llamazares, G. A., Berganzo, J., Hernández-Laín, A., Santolaria, J., Doblaré, M., Hubert, C., Rich, J. N., Sánchez-Gómez, P., Pérez-García, V. M., Ochoa, I., & Fernández, L. J. (2017). Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncology, 19(4), 503–513. https://doi.org/10.1093/neuonc/now230
Bader, S. B., Dewhirst, M. W., & Hammond, E. M. (2020). Cyclic hypoxia: An update on its characteristics, methods to measure it and biological implications in cancer. Cancers (Basel), 13(1), 23. https://doi.org/10.3390/cancers13010023
Blanco-Fernandez, B., Rey-Vinolas, S., Bağcı, G., Rubi-Sans, G., Otero, J., Navajas, D., Perez-Amodio, S., & Engel, E. (2022). Bioprinting decellularized breast tissue for the development of three-dimensional breast cancer models. ACS Applied Materials & Interfaces, 14(26), 29467–29482. https://doi.org/10.1021/acsami.2c00920
Bock, N., Forouz, F., Hipwood, L., Clegg, J., Jeffery, P., Gough, M., van Wyngaard, T., Pyke, C., Adams, M. N., Bray, L. J., Croft, L., Thompson, E. W., Kryza, T., & Meinert, C. (2023). GelMA, click-chemistry gelatin and bioprinted polyethylene glycol-based hydrogels as 3D ex vivo drug testing platforms for patient-derived breast cancer organoids. Pharmaceutics, 15(1), 261. https://doi.org/10.3390/pharmaceutics15010261
Brown, J. M., & Wilson, W. R. (2004). Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer, 4(6), 437–447. https://doi.org/10.1038/nrc1367
Burkholder-Wenger, A. C., Golzar, H., Wu, Y., & Tang, X. S. (2022). Development of a hybrid nanoink for 3D bioprinting of heterogeneous tumor models. ACS Biomaterials Science & Engineering, 8(2), 777–785. https://doi.org/10.1021/acsbiomaterials.1c01265
Calabretta, M. M., Ferri, M., Tassoni, A., Maiello, S., & Michelini, E. (2024). Novel bioassays based on 3D-printed device for sensing of hypoxia and p53 pathway in 3D cell models. Analytical and Bioanalytical Chemistry, 416(29), 6819–6826. https://doi.org/10.1007/s00216-024-05606-0
Chaturvedi, P., Gilkes, D. M., Wong, C. C. L., Kshitiz, Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., & Semenza, G. L. (2013). Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis. Journal of Clinical Investigation, 123(1), 189–205. https://doi.org/10.1172/jci64993
Chen, A., Sceneay, J., Gödde, N., Kinwel, T., Ham, S., Thompson, E. W., Humbert, P. O., & Möller, A. (2018). Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene, 37(31), 4214–4225. https://doi.org/10.1038/s41388-018-0259-3
Chen, H., Du, L., Li, J., Wu, Z., Gong, Z., Xia, Y., Fan, Z., Qian, Q., Ding, Z., Hu, H., & Guo, S. (2022). Modeling cancer metastasis using acoustically bio-printed patient-derived 3D tumor microtissues. Journal of Materials Chemistry B, 10(11), 1843–1852. https://doi.org/10.1039/d1tb02789a
Chermat, R., Refet-Mollof, E., Kamio, Y., Carrier, J. F., Wong, P., & Gervais, T. (2024). Brachytherapy on-a-chip: A clinically-relevant approach for radiotherapy testing in 3d biology. Lab on a Chip, 24(8), 2335–2346. https://doi.org/10.1039/d4lc00032c
Dankó, T., Petővári, G., Raffay, R., Sztankovics, D., Moldvai, D., Vetlényi, E., Krencz, I., Rókusz, A., Sipos, K., Visnovitz, T., Pápay, J., & Sebestyén, A. (2022). Characterisation of 3D bioprinted human breast cancer model for in vitro drug and metabolic targeting. International Journal of Molecular Sciences, 23(13), 7444. https://doi.org/10.3390/ijms23137444
de Heer, E. C., Jalving, M., & Harris, A. L. (2020). Hifs, angiogenesis, and metabolism: Elusive enemies in breast cancer. Journal of Clinical Investigation, 130(10), 5074–5087. https://doi.org/10.1172/jci137552
Desigaux, T., Comperat, L., Dusserre, N., Stachowicz, M.-L., Lea, M., Dupuy, J.-W., Vial, A., Molinari, M., Fricain, J.-C., Paris, F., & Oliveira, H. (2024). 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity. Bioactive Materials, 42, 316–327. https://doi.org/10.1016/j.bioactmat.2024.08.037
Dijkstra, K. K., Cattaneo, C. M., Weeber, F., Chalabi, M., van de Haar, J., Fanchi, L. F., Slagter, M., van der Velden, D. L., Kaing, S., Kelderman, S., van Rooij, N., van Leerdam, M. E., Depla, A., Smit, E. F., Hartemink, K. J., de Groot, R., Wolkers, M. C., Sachs, N., Snaebjornsson, P., … Voest, E. E. (2018). Generation of tumor-reactive t cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell, 174(6), 1586–1598.e12. https://doi.org/10.1016/j.cell.2018.07.009
Du, L., Zheng, Z., Zhang, K., Sun, H., Lu, Y., Sun, M., Pang, M., Jiang, S., He, Y., Du, S., Zhao, H., Mao, Y., Kang, W., Ge, P., & Yang, H. (2025). Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models. Molecular Cancer, 24(1), 259. https://doi.org/10.1186/s12943-025-02466-9
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15(1), 35–44. https://doi.org/10.1016/j.ccr.2008.11.012
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440(7088), 1222–1226. https://doi.org/10.1038/nature04695
Flores-Torres, S., Jiang, T., Kort-Mascort, J., Yang, Y., Peza-Chavez, O., Pal, S., Mainolfi, A., Pardo, L. A., Ferri, L., Bertos, N., Sangwan, V., & Kinsella, J. M. (2023). Constructing 3D in vitro models of heterocellular solid tumors and stromal tissues using extrusion-based bioprinting. ACS Biomaterials Science & Engineering, 9(2), 542–561. https://doi.org/10.1021/acsbiomaterials.2c00998
Fukuda, R., Zhang, H., Kim, J. W., Shimoda, L., Dang, C. V., & Semenza, G. L. (2007). HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell, 129(1), 111–122. https://doi.org/10.1016/j.cell.2007.01.047
Gallez, B. (2022). The role of imaging biomarkers to guide pharmacological interventions targeting tumor hypoxia. Frontiers in Pharmacology, 13, 853568. https://doi.org/10.3389/fphar.2022.853568
Ganesh, K., Wu, C., O’Rourke, K. P., Szeglin, B. C., Zheng, Y., Sauvé, C.-E. G., Adileh, M., Wasserman, I., Marco, M. R., Kim, A. S., Shady, M., Sanchez-Vega, F., Karthaus, W. R., Won, H. H., Choi, S.-H., Pelossof, R., Barlas, A., Ntiamoah, P., Pappou, E., … Smith, J. J. (2019). A rectal cancer organoid platform to study individual responses to chemoradiation. Nature Medicine, 25(10), 1607–1614. https://doi.org/10.1038/s41591-019-0584-2
Germain, N., Dhayer, M., Dekiouk, S., & Marchetti, P. (2022). Current advances in 3D bioprinting for cancer modeling and personalized medicine. International Journal of Molecular Sciences, 23(7), 3432. https://doi.org/10.3390/ijms23073432
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014). Hypoxia and the extracellular matrix: Drivers of tumour metastasis. Nature Reviews Cancer, 14(6), 430–439. https://doi.org/10.1038/nrc3726
Godier, C., Baka, Z., Lamy, L., Gribova, V., Marchal, P., Lavalle, P., Gaffet, E., Bezdetnaya, L., & Alem, H. (2024). A 3D bio-printed-based model for pancreatic ductal adenocarcinoma. Diseases, 12(9), 206. https://doi.org/10.3390/diseases12090206
Grimes, D. R., Kelly, C., Bloch, K., & Partridge, M. (2014). A method for estimating the oxygen consumption rate in multicellular tumour spheroids. Journal of the Royal Society Interface, 11(92), 20131124. https://doi.org/10.1098/rsif.2013.1124
Grün, C., Nies, C., Klesen, M., Schwarz, E., ter Haseborg, J., Dettmer, C., Beyer, C., Funk, L., & Gottwald, E. (2026). High-throughput analysis of 3D cell culture oxygen consumption using sensor arrays: A novel platform for hypoxia/normoxia research. Organoids, 5(1), 5. https://doi.org/10.3390/organoids5010005
Horder, H., Böhringer, D., Endrizzi, N., Hildebrand, L. S., Cianciosi, A., Stecher, S., Dusi, F., Schweinitzer, S., Watzling, M., Groll, J., Jüngst, T., Teßmar, J., Bauer-Kreisel, P., Fabry, B., & Blunk, T. (2024). Cancer cell migration depends on adjacent ASC and adipose spheroids in a 3D bioprinted breast cancer model. Biofabrication, 16(3), 035031. https://doi.org/10.1088/1758-5090/ad57f7
Horder, H., Guaza Lasheras, M., Grummel, N., Nadernezhad, A., Herbig, J., Ergün, S., Teßmar, J., Groll, J., Fabry, B., Bauer-Kreisel, P., & Blunk, T. (2021). Bioprinting and differentiation of adipose-derived stromal cell spheroids for a 3D breast cancer-adipose tissue model. Cells, 10(4), 803. https://doi.org/10.3390/cells10040803
Isik, S., Yucel, D., & Hasirci, V. (2026). Modeling a hypoxia-integrated glioblastoma microenvironment to mimic tumor heterogeneity and chemoresistance. Biomaterials Science, 14(15), 3963–3981. https://doi.org/10.1039/d5bm01824b
Iuele, H., Forciniti, S., Onesto, V., Colella, F., Siciliano, A. C., Chandra, A., Nobile, C., Gigli, G., & Del Mercato, L. L. (2024). Facile one pot synthesis of hybrid core-shell silica-based sensors for live imaging of dissolved oxygen and hypoxia mapping in 3D cell models. ACS Applied Materials & Interfaces, 16(41), 55071–55085. https://doi.org/10.1021/acsami.4c08306
Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., von Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001). Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292(5516), 468–472. https://doi.org/10.1126/science.1059796
Jung, M., Ghamrawi, S., Du, E. Y., Gooding, J. J., & Kavallaris, M. (2022). Advances in 3D bioprinting for cancer biology and precision medicine: From matrix design to application. Advanced Healthcare Materials, 11(24), 2200690. https://doi.org/10.1002/adhm.202200690
Keeley, T. P., & Mann, G. E. (2019). Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiological Reviews, 99(1), 161–234. https://doi.org/10.1152/physrev.00041.2017
Khurana, T., Thomas, S., Sudhakar, S., Edwards, S. M., Bearon, R. N., & Raj M, K. (2026). Drug transport in spheroids on a microfluidic tumor-on-chip platform: An integrated computational and experimental study. Biomicrofluidics, 20(4), 044105. https://doi.org/10.1063/5.0339813
Kim, J. W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism, 3(3), 177–185. https://doi.org/10.1016/j.cmet.2006.02.002
Knobloch-Sperlich, D., Kappler, M., Glaß, M., Güttler, A., Petrenko, M., Pyko, J., Gutschner, T., Tavasol, F., Vordermark, D., & Bache, M. (2026). Two-color spheroid model for determining the O2-induced radiosensitivity of HNSCC. Journal of Biological Engineering, 20(1), 17. https://doi.org/10.1186/s13036-025-00611-y
Krajewska, U., Chechlińska, M., & Kurzyk, A. (2026). Vascularisation in 3D bioprinted models: Emerging solutions engineering functional tissues and tumour models. Biofabrication, 18(2), 022001. https://doi.org/10.1088/1758-5090/ae2f02
Lansche, C., Ladaigue, S., Gropplero, G., Zimmermann, N., Nurmik, M., Veith, I., Nguyen, M.-L., Brosseau, S., Poté, N., Mordant, P., Roussel, A., Mami-Chouaib, F., Mechta-Grigoriou, F., Zalcman, G., Soncin, F., Descroix, S., & Parrini, M. C. (2025). Bioengineering a patient‐derived vascularized lung tumor‐on‐chip model to decipher immunomodulation by the endothelium. Advanced Healthcare Materials, 14(25), 2403446. https://doi.org/10.1002/adhm.202403446
Lee, D., Lee, S.-H., Jung, Y., Lee, J., Choi, M.-S., Oh, S., Kim, S., Kim, B. S., & Jeong, S. (2026). Microenvironment‐guided evolution of ssdna‐swcnt probes for selective recognition of aggressive prostate cancer phenotypes. Advanced Science (Weinh), 13(17), e18582. https://doi.org/10.1002/advs.202518582
Li, M., Freeman, S., Franco-Barraza, J., Cai, K. Q., Kim, A., Jin, S., Cukierman, E., & Ye, K. (2024). A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism. Biomaterials, 310, 122631. https://doi.org/10.1016/j.biomaterials.2024.122631
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15(6), 501–513. https://doi.org/10.1016/j.ccr.2009.03.018
Mao, S., He, J., Zhao, Y., Liu, T., Xie, F., Yang, H., Mao, Y., Pang, Y., & Sun, W. (2020). Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: Establishment, evaluation and anti-cancer drug testing. Biofabrication, 12(4), 045014. https://doi.org/10.1088/1758-5090/aba0c3
Molley, T. G., Jiang, S., Ong, L., Kopecky, C., Ranaweera, C. D., Jalandhra, G. K., Milton, L., Kardia, E., Zhou, Z., Rnjak-Kovacina, J., Waters, S. A., Toh, Y.-C., & Kilian, K. A. (2023). Gas-modulating microcapsules for spatiotemporal control of hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 120(16), e2217557120. https://doi.org/10.1073/pnas.2217557120
Mukomoto, R., Nashimoto, Y., Terai, T., Imaizumi, T., Hiramoto, K., Ino, K., Yokokawa, R., Miura, T., & Shiku, H. (2020). Oxygen consumption rate of tumour spheroids during necrotic-like core formation. Analyst, 145(19), 6342–6348. https://doi.org/10.1039/d0an00979b
Nasiri, R., Kurosu Jalil, M., Ibanez Gaspar, V., Flores Perez, A. S., Nguyen, H. T. M., Khan, S., Tang, S. K. Y., Yang, Y. P., & Pratx, G. (2025). A lung tumor-on-a-chip model recapitulates the effect of hypoxia on radiotherapy response and FDG-PET imaging. Lab on a Chip, 25(18), 4677–4691. https://doi.org/10.1039/d5lc00373c
Nasri, D., Manwar, R., Kaushik, A., Er, E. E., & Avanaki, K. (2023). Photoacoustic imaging for investigating tumor hypoxia: A strategic assessment. Theranostics, 13(10), 3346–3367. https://doi.org/10.7150/thno.84253
Neufeld, L., Yeini, E., Pozzi, S., & Satchi-Fainaro, R. (2022). 3D bioprinted cancer models: From basic biology to drug development. Nature Reviews Cancer, 22(12), 679–692. https://doi.org/10.1038/s41568-022-00514-w
Ning, L., Shim, J., Tomov, M. L., Liu, R., Mehta, R., Mingee, A., Hwang, B., Jin, L., Mantalaris, A., Xu, C., Mahmoudi, M., Goldsmith, K. C., & Serpooshan, V. (2022). A 3D bioprinted in vitro model of neuroblastoma recapitulates dynamic tumor‐endothelial cell interactions contributing to solid tumor aggressive behavior. Advanced Science (Weinh), 9(23), 2200244. https://doi.org/10.1002/advs.202200244
Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., Terris, D. J., & Overgaard, J. (2005). Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. an international multi-center study. Radiotherapy and Oncology, 77(1), 18–24. https://doi.org/10.1016/j.radonc.2005.06.038
Oh, J. M., Begum, H. M., Liu, Y. L., Ren, Y., & Shen, K. (2022). Recapitulating tumor hypoxia in a cleanroom-free, liquid-pinning-based microfluidic tumor model. ACS Biomaterials Science & Engineering, 8(7), 3107–3121. https://doi.org/10.1021/acsbiomaterials.2c00207
Okkelman, I. A., Vercruysse, C., Kondrashina, A. V., Borisov, S. M., & Dmitriev, R. I. (2022). Affordable oxygen microscopy-assisted biofabrication of multicellular spheroids. Journal of Visualized Experiments, (182), e63403. https://doi.org/10.3791/63403
Ooft, S. N., Weeber, F., Dijkstra, K. K., McLean, C. M., Kaing, S., van Werkhoven, E., Schipper, L., Hoes, L., Vis, D. J., van de Haar, J., Prevoo, W., Snaebjornsson, P., van der Velden, D., Klein, M., Chalabi, M., Boot, H., van Leerdam, M., Bloemendal, H. J., Beerepoot, L. V., … Voest, E. E. (2019). Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Science Translational Medicine, 11(513), eaay2574. https://doi.org/10.1126/scitranslmed.aay2574
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metabolism, 3(3), 187–197. https://doi.org/10.1016/j.cmet.2006.01.012
Park, W., Bae, M., Hwang, M., Jang, J., Cho, D. W., & Yi, H. G. (2021). 3D cell-printed hypoxic cancer-on-a-chip for recapitulating pathologic progression of solid cancer. Journal of Visualized Experiments, (167), e61945. https://doi.org/10.3791/61945
Parodi, I., Palamà, M. E. F., Di Lisa, D., Pastorino, L., Lagazzo, A., Falleroni, F., Aiello, M., Fato, M. M., & Scaglione, S. (2025). Core-shell hydrogels with tunable stiffness for breast cancer tissue modelling in an organ-on-chip system. Gels, 11(5), 356. https://doi.org/10.3390/gels11050356
Poljak, I., Chiappini, C., & Adriani, G. (2026). Engineering perfusion to meet tumor biology: Are vascularized tumor-on-a-chip models ready to drive therapy innovation? Lab on a Chip, 26(5), 1162–1190. https://doi.org/10.1039/d5lc01060h
Pyne, E., Reardon, M., Christensen, M., Rodriguez Mateos, P., Taylor, S., Iles, A., Choudhury, A., Pamme, N., & Pires, I. M. (2024). Investigating the impact of the interstitial fluid flow and hypoxia interface on cancer transcriptomes using a spheroid-on-chip perfusion system. Lab on a Chip, 24(19), 4609–4622. https://doi.org/10.1039/d4lc00512k
Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19(11), 1423–1437. https://doi.org/10.1038/nm.3394
Rafik, S. T., Ho, J., MacRobert, A. J., & Cheema, U. (2026). Engineering complex breast tumor-stroma models: TMPyP4-photodynamic therapy is more effective at the metastatic site in breast tumors. ACS Biomaterials Science & Engineering, 12(1), 515–530. https://doi.org/10.1021/acsbiomaterials.5c01341
Ramos, L., Robinson, M., Lallous, N., Flannigan, R., & Daugaard, M. (2026). Recent advances in purpose-built 3D bioprinted cancer models for drug development. Expert Opinion on Drug Discovery, 21(5), 475–490. https://doi.org/10.1080/17460441.2026.2642320
Refet-Mollof, E., Najyb, O., Chermat, R., Glory, A., Lafontaine, J., Wong, P., & Gervais, T. (2021). Hypoxic jumbo spheroids on-a-chip (honachip): Insights into treatment efficacy. Cancers (Basel), 13(16), 4046. https://doi.org/10.3390/cancers13164046
Ruan, Y., He, L., Chen, J., Wang, J., Zhao, S., Guo, X., Xie, Y., Cai, Z., Shen, X., & Li, C. (2023). Three-dimensional core-shell alginate microsphere for cancer hypoxia simulation in vitro. Frontiers in Bioengineering and Biotechnology, 11, 1174206. https://doi.org/10.3389/fbioe.2023.1174206
Schito, L., & Rey-Keim, S. (2026). HyPIC-3D enables characterization of migratory cancer cell subpopulations in 3D hypoxic microenvironments. Cell Reports Methods, 6(6), 101454. https://doi.org/10.1016/j.crmeth.2026.101454
Schito, L., & Semenza, G. L. (2016). Hypoxia-inducible factors: Master regulators of cancer progression. Trends in Cancer, 2(12), 758–770. https://doi.org/10.1016/j.trecan.2016.10.016
Seidel, S., Garvalov, B. K., Wirta, V., von Stechow, L., Schänzer, A., Meletis, K., Wolter, M., Sommerlad, D., Henze, A.-T., Nistér, M., Reifenberger, G., Lundeberg, J., Frisén, J., & Acker, T. (2010). A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α. Brain, 133(4), 983–995. https://doi.org/10.1093/brain/awq042
Shi, T. H., Huang, Y.-T., Jeon, H., Montes-Pinzon, D., Chang, P. M.-H., Chiang, N.-J., Sinclair, J. A., Taglione, A., Hanjaya-Putra, D., Wang, Y., Huang, C.-Y. F., & Chang, H.-C. (2026). Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screens. APL Bioengineering, 10(1), 016113. https://doi.org/10.1063/5.0304565
Shirure, V. S., Bi, Y., Curtis, M. B., Lezia, A., Goedegebuure, M. M., Goedegebuure, S. P., Aft, R., Fields, R. C., & George, S. C. (2018). Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab on a Chip, 18(23), 3687–3702. https://doi.org/10.1039/c8lc00596f
Shukla, P., Bera, A. K., Yeleswarapu, S., & Pati, F. (2024). High throughput bioprinting using decellularized adipose tissue‐based hydrogels for 3D breast cancer modeling. Macromolecular Bioscience, 24(8), e2400035. https://doi.org/10.1002/mabi.202400035
Shukla, P., Yeleswarapu, S., Heinrich, M. A., Prakash, J., & Pati, F. (2022). Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling. Biofabrication, 14(3), 032002. https://doi.org/10.1088/1758-5090/ac6d11
Singleton, D. C., Macann, A., & Wilson, W. R. (2021). Therapeutic targeting of the hypoxic tumour microenvironment. Nature Reviews Clinical Oncology, 18(12), 751–772. https://doi.org/10.1038/s41571-021-00539-4
Skubal, M., Larney, B. M., Phung, N. B., Desmaras, J. C., Dozic, A. V., Volpe, A., Ogirala, A., Machado, C. L., Djibankov, J., Ponomarev, V., & Grimm, J. (2025). Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies. Theranostics, 15(3), 766–783. https://doi.org/10.7150/thno.95334
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016). 3D microtumors in vitro supported by perfused vascular networks. Scientific Reports, 6(1), 31589. https://doi.org/10.1038/srep31589
Sun, H., Wang, Y., Sun, M., Ke, X., Li, C., Jin, B., Pang, M., Wang, Y., Jiang, S., Du, L., Du, S., Zhong, S., Zhao, H., Pang, Y., Sun, Y., Yang, Z., Yang, H., & Mao, Y. (2025). Developing patient-derived 3D-bioprinting models of pancreatic cancer. Journal of Advanced Research, 74, 165–174. https://doi.org/10.1016/j.jare.2024.09.011
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. American Journal of Pathology, 157(2), 411–421. https://doi.org/10.1016/s0002-9440(10)64554-3
Tang, G., Peng, Z., Zhao, Y., Chen, X., Huang, S., Chen, G., & Guo, W. (2026). A vascularized 3D-bioprinted model of the osteosarcoma microenvironment reveals a proliferation-to-invasion switch that confers chemoresistance. International Journal of Bioprinting, 12(2), 026040031. https://doi.org/10.36922/ijb026040031
Telarovic, I., Wenger, R. H., & Pruschy, M. (2021). Interfering with tumor hypoxia for radiotherapy optimization. Journal of Experimental & Clinical Cancer Research, 40(1), 197. https://doi.org/10.1186/s13046-021-02000-x
Terrassoux, L., Hazard, C., Laratte, A., Balsamelli, J., Arcicasa, M., Fong, E., Baland, L., Soncin, F., Cappello, G., Maurage, C.-A., Janel, S., Bazir, A., Cleri, F., Treizebre, A., Lartigau, E., Rekik, Y., Meignan, S., & Furlan, A. (2025). Novel diffuse midline glioma‐on‐chip recapitulating tumor biophysical microenvironment to assess the heterogeneity of response to therapies. Small, 21(45), e05343. https://doi.org/10.1002/smll.202505343
Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., Miyabayashi, K., Young, C. M., Patel, H., Ma, M., LaComb, J. F., Palmaira, R. L. D., Javed, A. A., Huynh, J. C., Johnson, M., … Tuveson, D. A. (2018). Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery, 8(9), 1112–1129. https://doi.org/10.1158/2159-8290.cd-18-0349
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., Rata, M., Koh, D.-M., Tunariu, N., Collins, D., Hulkki-Wilson, S., Ragulan, C., Spiteri, I., Moorcraft, S. Y., Chau, I., … Valeri, N. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science, 359(6378), 920–926. https://doi.org/10.1126/science.aao2774
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92(12), 5510–5514. https://doi.org/10.1073/pnas.92.12.5510
Wicks, E. E., & Semenza, G. L. (2022). Hypoxia-inducible factors: Cancer progression and clinical translation. Journal of Clinical Investigation, 132(11), e159839. https://doi.org/10.1172/jci159839
Wong, C. C. L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., Wirtz, D., & Semenza, G. L. (2011). Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proceedings of the National Academy of Sciences of the United States of America, 108(39), 16369–16374. https://doi.org/10.1073/pnas.1113483108
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008). Direct regulation of TWIST by HIF-1α promotes metastasis. Nature Cell Biology, 10(3), 295–305. https://doi.org/10.1038/ncb1691
Yao, E. J., Lu, G. Y., Vadla, R., Xiang, Y., Lu, T.-Y., Sun, Y., Berman, E. L., Zhang, N., Furnari, F., & Chen, S. (2026). Forming a precise and reproducible hypoxic tumor microenvironment in glioblastoma by high cell density bioprinting. Advanced Healthcare Materials, 15(26), e71322. https://doi.org/10.1002/adhm.71322
Yi, H.-G., Jeong, Y.-H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., Paek, S. H., & Cho, D.-W. (2019). A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nature Biomedical Engineering, 3(7), 509–519. https://doi.org/10.1038/s41551-019-0363-x
Ziółkowska-Suchanek, I. (2021). Mimicking tumor hypoxia in non-small cell lung cancer employing three-dimensional in vitro models. Cells, 10(1), 141. https://doi.org/10.3390/cells10010141
